$15.04
Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Replimune to Present at the Cantor Global Healthcare Conference 2026
Why Did SJM, REPL, NEO Stocks Surge To 52-Week Highs Today?
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Overview
52-week range
$1.50
$16
91% of range
Avg surprise (last 2)
-11.9%
Avg reaction (last 1)
+3.5%
100% positive
Latest IV / EM
188%
EM ±7.8% · $16 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.72 | — | — | — | — | financials |
| Wed Dec 31, 2025 | Dec 2025 | $-0.77 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $-0.90 | — | — | — | — | financials |
| Thu Aug 7, 2025 | Jun/2025 | $-0.95 | $-0.83 | -14.5% | — | — | earnings |
| Thu May 22, 2025 | Mar/2025 | $-0.82 | $-0.75 | -9.3% | — | +3.5% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $-0.79 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $-0.68 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.78 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $-0.77 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.90 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.75 | — | — | — | — | financials |
| Sat Dec 31, 2022 | Dec 2022 | $-0.69 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-68M | — | $-72M | $-84M | $-90M | — | $-66M | $-59M |
| Net income | $-70M | — | $-71M | $-83M | $-87M | — | $-66M | $-53M |
| EPS (diluted) | $-0.72 | — | $-0.77 | $-0.90 | $-0.95 | — | $-0.79 | $-0.68 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $185M | $209M | $123M | $102M | $97M | $111M | $172M | $113M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $201M | $279M | $280M | $334M | $413M | $496M | $548M | $443M |
| Total assets | $252M | $332M | $334M | $389M | $470M | $551M | $604M | $498M |
| Long-term debt | $84M | $83M | $48M | $47M | $47M | $46M | $46M | $46M |
| Total liabilities | $147M | $166M | $123M | $126M | $133M | $135M | $121M | $117M |
| Total equity | $106M | $166M | $211M | $263M | $337M | $416M | $482M | $381M |